Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Significant Drop in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 200 shares, a drop of 80.0% from the February 28th total of 1,000 shares. Based on an average trading volume of 1,300 shares, the days-to-cover ratio is currently 0.2 days.

Hikma Pharmaceuticals Stock Performance

OTCMKTS HKMPY traded up $0.44 during trading hours on Thursday, reaching $52.07. 321 shares of the company were exchanged, compared to its average volume of 909. The business’s 50 day simple moving average is $55.23 and its 200-day simple moving average is $51.63. Hikma Pharmaceuticals has a 1 year low of $46.16 and a 1 year high of $59.26.

Hikma Pharmaceuticals Increases Dividend

The company also recently announced a dividend, which will be paid on Monday, May 12th. Stockholders of record on Friday, March 21st will be issued a dividend of $0.94 per share. The ex-dividend date of this dividend is Friday, March 21st. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.62. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is currently 10.34%.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.